Abstract
The hormone progesterone is readily converted to 3α-OH-5α-pregnan-20-one (3α,5α-THP) in the brains of males and females1,2. In the brain, 3α,5α-THP acts like a sedative3,4,5, decreasing anxiety and reducing seizure activity, by enhancing the function of GABA (γ-aminobutyric acid)6,7,8, the brain's major inhibitory neurotransmitter. Symptoms of premenstrual syndrome (PMS), such as anxiety9 and seizure10,11 susceptibility, are associated with sharp declines in circulating levels of progesterone and, consequently, of levels of 3α,5α-THP in the brain. Abrupt discontinuation of use of sedatives such as benzodiazepines12 and ethanol13 can also produce PMS-like withdrawal symptoms. Here we report a progesterone-withdrawal paradigm, designed to mimic PMS and post-partum syndrome in a rat model. In this model, withdrawal of progesterone leads to increased seizure susceptibility and insensitivity to benzodiazepine sedatives through an effect on gene transcription. Specifically, this effect was due to reduced levels of 3α,5α-THP which enhance transcription of the gene encoding the α4 subunit of the GABAA receptor. We also find that increased susceptibility to seizure after progesterone withdrawal is due to a sixfold decrease in the decay time for GABA currents and consequent decreased inhibitory function. Blockade of the α4 gene transcript prevents these withdrawal properties. PMS symptoms may therefore be attributable, in part, to alterations in expression of GABAA receptor subunits as a result of progesterone withdrawal.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Smith, S. S. Female sex steroids: from receptors to networks to performance—actions on the sensorimotor system. Prog. Neurobiol. 44, 55–86 (1994).
Purdy, R. H., Morrow, A. L., Moore, P. H. J & Paul, S. M. Stress-induced elevations of GABA type A receptor-active steroids in the rat brain. Proc. Natl Acad. Sci. USA 88, 4553–4557 (1991).
Bitran, D., Hilvers, R. J. & Kellogg, C. K. Anxiolytic effects of 3α-OH-5α[β]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAAreceptor. Brain Res. 561, 157–161 (1991).
Brot, M. D., Akwa, Y., Purdy, R. H., Koob, G. F. & Britton, K. T. The anxiolytic-like effects of the neurosteroid allopregnanolone–interactions with GABAAreceptors. Eur. J. Pharmacol. 325, 1–7 (1997).
Belelli, D., Bolger, M. B. & Gee, K. Anticonvulsant profile of the progesterone metabolite 5α-pregnan-3α-ol-20-one. Eur. J. Pharmacol. 166, 325–329 (1989).
Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L. & Paul, S. M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232, 1004–1007 (1986).
Smith, S. S., Waterhouse, B. . D., Chapin, J. K. & Woodward, D. J. Progesterone alters GABA and glutamate responsiveness: a possible mechanism for its anxiolytic action. Brain Res. 400, 353–359 (1987).
Twyman, R. E. & MacDonald, R. L. Neurosteroid regulation of GABAAreceptor-single channel kinetic properties of mouse spinal cord neurons in culture. J. Physiol. (Lond.) 456, 215–245 (1992).
Dennerstein, L. et al. Progesterone and premenstrual syndrome: a double blind crossover trial. Brit. Med. J. 290, 1617–1621 (1985).
Backstrom, T., Zetterlund, B., Blom, S. & Romano, M. Effects of intravenous progesterone infusions on the epileptic discharge frequency in women with partial epilepsy. Acta Neurol. Scand. 69, 240–248 (1984).
Herzog, A. G. Progesterone therapy in women with complex partial and secondary generalized seizures. Neurology 45, 1660–1662 (1995).
File, S. E. The history of benzodiazepine dependence: a review of animal studies. Neurosci. Biobehav. Rev. 14, 135–146 (1990).
Kokka, N., Sapp, D. W., Taylor, A. M. & Olsen, R. W. The kindling model of alcohol dependence: similar persistent reduction in seizure threshold to pentylenetetrazol in animals receiving chronic ethanol or chronic pentylenetetrazol. Alcohol Clin. Exp. Res. 17, 525–531 (1993).
Costa, A.-M. N., Spence, K. T., Smith, S. S. & ffrench-Mullen, J. M. H. Withdrawal from the endogenous steroid progesterone results in GABAAcurrents insensitive to benzodiazepine modulation in rat CA1 hippocampus. J. Neurophys. 74, 464–469 (1995).
Friedman, L., Gibbs, T. T. & Farb, D. H. γ-Aminobutyric acidAreceptor regulation: Chronic treatment with pregnanolone uncouples allosteric interactions between steroid and benzodiazepine recognition sites. Mol. Pharmacol. 44, 191–197 (1993).
Buck, K. J. & Harris, R. A. Benzodiazepine agonist and ivnerse agonist actions on GABAAreceptor-operated chloride channels. II. Chronic effects of ethanol. J. Pharmacol. Exp. Ther. 253, 713–719 (1990).
Yu, X. J. & Ticku, M. K. Chronic neurosteroid treatment produces functional heterologous uncoupling at the gamma-aminobutyric acid type A/benzodiazepine receptor complex in mammalian cortical neurons. Mol. Pharmacol. 47, 603–610 (1994).
Ator, N. A., Grant, K. A., Purdy, R. H., Paul, S. M. & Griffiths, R. R. Drug discrimination analysis of endogenous neuroactive steroids in rats. Eur. J. Pharmacol. 241, 237–243 (1993).
Sundstrom, I., Ashbrook, D. & Backstrom, T. Reduced benzodiazepine sensitivity in patients with premenstrual syndrome—a pilot study. Psychoneuroendo 22, 25–38 (1997).
Gallo, M. A. & Smith, S. S. Progesterone withdrawal decreases latency to and increases duration of electrified prod burial: a possible rat model of PMS anxiety. Pharmacol. Biochem. Behav. 46, 897–904 (1993).
Wafford, K. A. et al. Functional characterization of human GABA receptors containing the α4 subunit. Mol. Pharmacol. 50, 670–678 (1996).
Wisden, W. et al. Cloning, pharmacological characteristics and expression pattern of the rate GABAAreceptor α4 subunit. FEBS Lett. 289, 227–230 (1991).
Mahmoudi, M., Kang, M. H., Tillakaratne, N., Tobin, A. J. & Olsen, R. W. Chronic intermittent ethanol treatment in rats increases GABAAreceptor α4 subunit expression–possible relevance to alcohol dependence. J. Neurochem. 68, 2485–2492 (1997).
Devaud, L. L., Fritschy, J. M., Sieghart, W. & Morrow, A. L. Bidirectional alterations of GABAAreceptor subunit peptide levels in rat cortex during chronic ethanol consumption and withdrawal. J. Neurochem. 69, 126–130 (1997).
Holt, R. A., Bateson, A. N. & Martin, I. L. Chronic treatment with diazepam or abecarnil differently affects the expression of GABAAreceptor subunit mRNAs in the rat cortex. Neuropharmacol. 35, 1457–1463 (1996).
Lavoie, A. M., Tingey, J. J., Harrison, N. L., Pritchett, D. B. & Twyman, R. E. Activation and deactivation rates of recombinant GABA(A) receptor channels are dependent on alpha-subunit isoform. Biophys. J. 73, 1–9 (1997).
Kern, W. & Sieghart, W. Polyclonal antibodies directed against an epitope specific for the α4-subunit of GABAAreceptors identify a 67-kDa protein in rat brain membranes. J. Neurochem. 62, 764–769 (1994).
Mossier, B., Togel, M., Fuchs, K. & Sieghart, W. Immunoaffinity purification of GABAAreceptors containing γ2 subunits. J. Biol. Chem. 269, 25777–25782 (1994).
Tyndale, R. F., Hales, T. G., Olsen, R. W. & Tobin, A. J. Distinctive patterns of GABAAreceptor subunit mRNAs in 13 cell lines. J. Neurosci. 14, 5417–5428 (1994).
Lau, E. C., Li, Z.-Q., Santos, V. & Slavkin, H. C. Messenger RNA phenotyping for semi-quantitative comparison of glucocorticoid receptor transcript levels in the developing embryonic mouse palate. J. Steroid Biochem. Mol. Biol. 46, 751–758 ((1993).
Acknowledgements
We thank I. Fischer for assistance; Hoffman-La Roche for the RO15-1788 sample; D.S. Faber, M. M. McCarthy and D. H. Smith for critical reading of the manuscript; and D. O'Reilly for editorial comments. The work was supported by a grant from the NIH.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Smith, S., Gong, Q., Hsu, FC. et al. GABAA receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 392, 926–929 (1998). https://doi.org/10.1038/31948
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/31948
This article is cited by
-
Preclinical and clinical pharmacology of brexanolone (allopregnanolone) for postpartum depression: a landmark journey from concept to clinic in neurosteroid replacement therapy
Psychopharmacology (2023)
-
Brain reactivity during aggressive response in women with premenstrual dysphoric disorder treated with a selective progesterone receptor modulator
Neuropsychopharmacology (2021)
-
Plasma gamma-aminobutyric acid (GABA) levels and posttraumatic stress disorder symptoms in trauma-exposed women: a preliminary report
Psychopharmacology (2021)
-
Parallel modulation of intracortical excitability of somatosensory and visual cortex by the gonadal hormones estradiol and progesterone
Scientific Reports (2020)
-
Histone deacetylases mediate GABAA receptor expression, physiology, and behavioral maladaptations in rat models of alcohol dependence
Neuropsychopharmacology (2018)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.